FORT LAUDERDALE, Fla., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Endovia Health Sciences, Inc. ("Endovia" or the "Company") (NYSE:EDVA), in association with Lupvindol BioSciences ("Lupvindol"), today
Initial tranche assists CannEpil® development and commercialization Financing comes as FDA and Congress increase focus on advancing and incentivizing regulated development of botanical and plant-derived medicines FORT
Company views federal support for Schedule III as a significant evolution in U.S. cannabinoid policy and an important step toward a durable regulatory framework for cannabinoid-based medicines and wellness products
FORT LAUDERDALE, Fla., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Endovia Health Sciences, Inc. (NYSE:EDVA), formerly Splash Beverage Group, Inc. (NYSE:SBEV) ("Endovia Health" or the "Company") announced that
